The elimination of Hepatitis C as a global public health threat [ 2018 - ]

Research Grant

Researchers: Prof Margaret Hellard (Principal investigator) ,  Prof Alexander Thompson ,  Prof David Wilson

Brief description In Australia over 230,000 people live with chronic HCV infection, with an estimated annual health care cost of over > $6.5 billion if left untreated. New highly effective HCV medications - direct acting antivirals (DAAs) have a cure rate of > 90%. DAAs will revolutionise HCV care - we can now stop HCV related deaths and transmission making HCV elimination possible. This Program Grant will directly contribute to the global response to HCV elimination and Australia achieving elimination by 2030.

Funding Amount $7,001,475.00

Funding Scheme Programs

Notes Program Grant